Hetero receives DCG(I) approval for fixed-dose combination therapy ‘Ledipasvir-Sofosbuvir’
The product will be available under the brand name ‘Ledisof’ in India
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.